The Latest Breaking News from Chemotherapy

IN FOCUS: EXCLUSIVE: Cancer patients, oncologists and advocates tell Rhian Lubin why the US health insurance system needs urgent reform, and is risking the lives of Americans fighting the disease

Zymeworks Inc. (NASDAQ:ZYME) stock is surging on Monday, with a session volume of 2.17 million, compared to an average volume of 728.75K, according to Benzinga Pro.

Topic has been working out throughout the process and didn’t want the diagnosis revealed until after he started treatment

Oklahoma City Thunder say their 2024 first-round draft pick, Nikola Topic, is undergoing chemotherapy to treat testicular cancer

An early-stage study has found that a common chemotherapy drug disrupts lymphatic cells in the tissue surrounding the brain. This is linked to memory issues in mice.

The teenager underwent gruelling chemotherapy and radiotherapy for several months

Cancer treatment has come a long way, but many of today’s therapies still come with steep costs: not just financial, but physical and emotional too. Chemotherapy and radiotherapy remain vital tools, yet they often damage healthy cells alongside cancerous ones, leaving patients exhausted and vulnerable to long-term side effects.

The standard assumption is that once the medication is in a patient, that process is over. But that's not correct. The USP 800 standard recognizes that "handling body fluids (e.g., urine, feces, sweat, or vomit)" from patients treated with these life-altering chemicals is an avoidable risk.

Summit Therapeutics Inc. (NASDAQ:SMMT) stock is trading lower on Monday. The company shared progress on its lead drug candidate and third-quarter financial results.